Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DEXKETOPROFENO SANDOZ CARE 25 MG SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/DEXKETOPROFENO SANDOZ CARE 25 MG SOLUCION ORAL

Approved

STANDARD

DEXKETOPROFENO SANDOZ CARE 25 MG SOLUCION ORAL

Sandoz Farmaceutica S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 9, 2024
Approval ID: 699a2a83daa61bb9
Company: Sandoz Farmaceutica S.A.
Type: Standard

Approval Details

Approval Id: 699a2a83daa61bb9
Drug Cima Aemps Name: DEXKETOPROFENO SANDOZ CARE 25 MG SOLUCION ORAL
Register Number: 89550
Holder Company Name: Sandoz Farmaceutica S.A.
Marketing Company Name: Sandoz Farmaceutica S.A.
Authorization Date: 2024-05-09
Dosage Form: SOLUCION ORAL EN SOBRE
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Sandoz Farmaceutica S.A.

Active Ingredients

DEXKETOPROFENO TROMETAMOL

36,9 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 9, 2024

Approval ID

699a2a83daa61bb9

Type

Standard

Back to CIMA-AEMPS Approvals